Acinic Cell Carcinoma - 45 Studies Found
| Suspended |
: Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer :
|
| Recruiting |
: Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer :
|
| Completed |
: Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer :
|
| Completed |
: Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy :
|
| Active, not recruiting |
: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer :
|
| Active, not recruiting |
: Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery :
|
| Recruiting |
: Stereotactic Radiosurgery and Metformin Hydrochloride in Treating Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer :
|
| Active, not recruiting |
: CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer :
|
| Active, not recruiting |
: Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery :
|
| Recruiting |
: Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer :
|